Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Charles C Bell,
Katie A Fennell,
Yih-Chih Chan,
Florian Rambow,
Miriam M Yeung,
Dane Vassiliadis,
Luis Lara,
Paul Yeh,
Luciano G Martelotto,
Aljosja Rogiers,
Brandon E Kremer,
Olena Barbash,
Helai P Mohammad,
Timothy M Johanson,
Marian L Burr,
Arindam Dhar,
Natalie Karpinich,
Luyi Tian,
Dean S Tyler,
Laura MacPherson,
Junwei Shi,
Nathan Pinnawala,
Chun Yew Fong,
Anthony T Papenfuss,
Sean M Grimmond,
Sarah-Jane Dawson,
Rhys S Allan,
Ryan G Kruger,
Christopher R Vakoc,
David L Goode,
Shalin H Naik,
Omer Gilan,
Enid YN Lam,
Jean-Christophe Marine,
Rab K Prinjha,
Mark A Dawson
Aug 21, 2019
Non-genetic drug resistance is increasingly recognised in various cancers. Molecular insights into this process are lacking and it is unknown whether stable non-genetic resistance can be overcome. Using single cell...